{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:53:59Z","timestamp":1791395639865,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grant-in-Aid for Scientific Research","award":["23592125, 26462182"],"award-info":[{"award-number":["23592125, 26462182"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10014-019-00345-y","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T13:02:28Z","timestamp":1555938148000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["High-grade glioneuronal tumor with an ARHGEF2\u2013NTRK1 fusion gene"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6942-9919","authenticated-orcid":false,"given":"Kazuhiko","family":"Kurozumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hirato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Washio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"345_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jocn.2015.04.021","volume":"23","author":"M Nagaishi","year":"2016","unstructured":"Nagaishi M, Nobusawa S, Matsumura N et al (2016) SLC44A1\u2013PRKCA fusion in papillary and rosette-forming glioneuronal tumors. J Clin Neurosci 23:73\u201375","journal-title":"J Clin Neurosci"},{"key":"345_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/ng.3500","volume":"48","author":"P Bandopadhayay","year":"2016","unstructured":"Bandopadhayay P, Ramkissoon LA, Jain P et al (2016) MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat Genet 48:273","journal-title":"Nat Genet"},{"key":"345_CR3","unstructured":"Louis DN (2007) WHO classification of tumours of the central nervous system. Copenhagen, WHO Regional Office Europe"},{"key":"345_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/neup.12215","volume":"35","author":"H Momota","year":"2015","unstructured":"Momota H, Shimoyama Y (2015) Recurrent papillary glioneuronal tumor presenting as a ganglioglioma with the BRAF V600E mutation. Neuropathology 35:603\u2013605","journal-title":"Neuropathology"},{"key":"345_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-018-1865-4","volume":"136","author":"MY Deng","year":"2018","unstructured":"Deng MY, Sill M, Chiang J et al (2018) Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta neuropathologica 136:239\u2013253","journal-title":"Acta neuropathologica"},{"key":"345_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DT, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469","journal-title":"Nature"},{"key":"345_CR7","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1038\/onc.2014.406","volume":"34","author":"K Yoshihara","year":"2015","unstructured":"Yoshihara K, Wang Q, Torres-Garcia W et al (2015) The landscape and therapeutic relevance of cancer-associated transcript fusions. Oncogene 34:4845","journal-title":"Oncogene"},{"key":"345_CR8","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","volume":"368","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Kim D-W, Nakagawa K et al (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368:2385\u20132394","journal-title":"N Engl J Med"},{"key":"345_CR9","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/nm.3352","volume":"19","author":"A Vaishnavi","year":"2013","unstructured":"Vaishnavi A, Capelletti M, Le AT et al (2013) Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med 19:1469","journal-title":"Nat Med"},{"key":"345_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-016-0351-2","volume":"4","author":"H Arita","year":"2016","unstructured":"Arita H, Yamasaki K, Matsushita Y et al (2016) A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun 4:79","journal-title":"Acta Neuropathol Commun"},{"key":"345_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-013-1141-6","volume":"126","author":"H Arita","year":"2013","unstructured":"Arita H, Narita Y, Fukushima S et al (2013) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126:267\u2013276","journal-title":"Acta Neuropathol"},{"key":"345_CR12","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DTW Jones","year":"2008","unstructured":"Jones DTW, Kocialkowski S, Liu L et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673\u20138677","journal-title":"Cancer Res"},{"key":"345_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"345_CR14","doi-asserted-by":"publisher","first-page":"e000023","DOI":"10.1136\/esmoopen-2015-000023","volume":"1","author":"A Amatu","year":"2016","unstructured":"Amatu A, Sartore-Bianchi A, Siena S (2016) NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open 1:e000023","journal-title":"ESMO Open"},{"key":"345_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1517\/13543784.2015.1096344","volume":"24","author":"C Rolfo","year":"2015","unstructured":"Rolfo C, Ruiz R, Giovannetti E et al (2015) Entrectinib: a potent new TRK, ROS1, and ALK inhibitor. Expert Opin Investig Drugs 24:1493\u20131500","journal-title":"Expert Opin Investig Drugs"},{"key":"345_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/cancers10040105","volume":"10","author":"AM Lange","year":"2018","unstructured":"Lange AM, Lo H-W (2018) Inhibiting TRK proteins in clinical Cancer therapy. Cancers 10:105","journal-title":"Cancers"},{"key":"345_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41698-017-0009-y","volume":"1","author":"C Alvarez-Breckenridge","year":"2017","unstructured":"Alvarez-Breckenridge C, Miller JJ, Nayyar N et al (2017) Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor. NPJ Precis Oncol 1:5","journal-title":"NPJ Precis Oncol"},{"key":"#cr-split#-345_CR18.1","unstructured":"Burris HA, Shaw AT, Bauer TM et al (2015) Pharmacokinetics"},{"key":"#cr-split#-345_CR18.2","doi-asserted-by":"crossref","unstructured":"(PK) of LOXO-101 during the first-in-human phase I study in patients with advanced solid tumors: interim update. In: AACR-2015 2015, Abstract No. 4529","DOI":"10.1158\/1538-7445.AM2015-4529"},{"key":"345_CR19","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1158\/1535-7163.MCT-14-1105","volume":"14","author":"BD Smith","year":"2015","unstructured":"Smith BD, Kaufman MD, Leary CB et al (2015) Altiratinib inhibits tumor growth, invasion, angiogenesis, and microenvironment-mediated drug resistance via balanced inhibition of MET, TIE2, and VEGFR2. Mol Cancer Ther 14:2023\u20132034","journal-title":"Mol Cancer Ther"},{"key":"345_CR20","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.18632\/oncotarget.6547","volume":"7","author":"PP Patwardhan","year":"2016","unstructured":"Patwardhan PP, Ivy KS, Musi E et al (2016) Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma. Oncotarget 7:4093","journal-title":"Oncotarget"},{"key":"345_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/nm.3729","volume":"20","author":"Z Zheng","year":"2014","unstructured":"Zheng Z, Liebers M, Zhelyazkova B et al (2014) Anchored multiplex PCR for targeted next-generation sequencing. Nat Med 20:1479","journal-title":"Nat Med"},{"key":"345_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu G, Diaz AK, Paugh BS et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444","journal-title":"Nat Genet"},{"key":"345_CR23","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1227\/NEU.0b013e3182500a4c","volume":"70","author":"DG Southwell","year":"2012","unstructured":"Southwell DG, Garcia PA, Berger MS et al (2012) Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery 70:1406\u20131414","journal-title":"Neurosurgery"},{"key":"345_CR24","unstructured":"Reifenberger G, Rodriguez F, Burger P et al (2016) Diffuse leptomeningeal glioneuronal tumour. WHO Classification of Tumours of the Central Nervous System, Revised. 4th edn. International Agency for Research Centre, Lyon, pp 152\u2013155."},{"key":"345_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.humpath.2017.06.004","volume":"70","author":"KE Schwetye","year":"2017","unstructured":"Schwetye KE, Kansagra AP, McEachern J et al (2017) Unusual high-grade features in pediatric diffuse leptomeningeal glioneuronal tumor: comparison with a typical low-grade example. Hum Pathol 70:105\u2013112","journal-title":"Hum Pathol"},{"key":"345_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-016-1611-8","volume":"132","author":"E Tabouret","year":"2016","unstructured":"Tabouret E, Nguyen AT, Dehais C et al (2016) Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort. Acta Neuropathol 132:625\u2013634","journal-title":"Acta Neuropathol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-019-00345-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-019-00345-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-019-00345-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T13:50:37Z","timestamp":1663336237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-019-00345-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1007\/s10014-019-00345-y","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}